SK pharmteco doubles viral vector production capacity in Europe
(Adnkronos) – SEOUL, South Korea, June 23, 2023 /PRNewswire/ — SK pharmteco, SK Inc.’s contract development manufacturing organization (CDMO) for pharmaceuticals, successfully completed its second facility for Cell and Gene Therapies (C>)
